Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
基本信息
- 批准号:7123488
- 负责人:
- 金额:$ 36.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-29 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS therapyalternative medicineantioxidantsantiviral agentsascorbatebiological signal transductionchemopreventionendothelinenzyme activityfree radical oxygengap junctionsgene expressionginkgo bilobahuman immunodeficiency virushuman tissuenitric oxide synthaseoxidative stresspharmacokineticsprostaglandinspulmonary hypertensionrespiratory epitheliumswinetissue /cell culturetocopherolsvascular endothelium permeabilityvasomotion
项目摘要
DESCRIPTION (provided by applicant): The incidence of HIV-related pulmonary hypertension has been recognized in the last few years with increasing frequency. However, the etiology and underlying molecular mechanisms of this serious complication are unknown. Recent clinical reports indicate that highly active antiretroviral therapy (HAART) may increase the incidence of HIV-related pulmonary hypertension. Our preliminary data have demonstrated that some HAART drugs impaired endothelium-dependent vasorelaxation, reduced the expression of endothelial nitric oxide synthase (eNOS), and increased super oxide anion production in porcine pulmonary arteries in vitro. In addition, some HAART drugs increased endothelial permeability and oxidative stress, and decreased the expression of several junctional molecules inhuman pulmonary artery endothelial cells (HPAECs). Furthetntore, ginsenoside Rbl and ginkgolide A effectively blocked some HAART drug-induced endothelial dysfunction. Based on these studies, we have developed our central hypotheses that some HAART drugs may cause endothelial dysfunction and oxidative stress in pulmonary arteries through unique molecular pathways, and ginseng and ginkgo compounds may effectively block these detrimental effects of HAART drugs on pulmonary arteries. Thus, we propose a multidisciplinary study to test these central hypotheses. Four specific aims are proposed.
Aim 1 is designed to determine the effect of HAART drugs on vasomotor activities and the eNOS system in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will investigate the vasomotor activities, eNOS expression, signal transduction pathways, and prostaglandin and endothelin systems.
Aim 2 is designed to determine the effect of HAART drugs on endothelial permeability, junction structures, and molecules in human pulmonary artery endothelial cells. We will investigate endothelial permeability, junction molecular expression, and regulation as well as signal transduction pathways.
Aim 3 is designed to determine the effect of HAART drugs on the reactive oxygen species (ROS) system in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will investigate the types and molecular sources of ROS production, the activities and gene expression of ROS-generating and internal antioxidant enzymes.
Aim 4 is designed to determine the effect of ginseng and ginkgo compounds on HAART drug induced-endothelial dysfunction and oxidative stress in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will study whether ginseng and ginkgo compounds can block some HAART drug-induced vasomotor dysfunction and permeability increase as well as oxidative stress and related gene expression and regulation. The differences of ginseng and ginkgo compounds will be compared with vitamins C and E in blocking HAART-induced endothelial dysfunction.
This study will elucidate the molecular mechanisms of HAART drugs' action on pulmonary endothelial cells and provide valuable information for the development of effective strategies for the prevention and treatment of HIV-related pulmonary hypertension.
描述(由申请者提供):艾滋病毒相关性肺动脉高压的发病率在过去几年中已被认识到,而且频率越来越高。然而,这一严重并发症的病因和潜在的分子机制尚不清楚。最近的临床报道表明,高效抗逆转录病毒治疗(HAART)可能会增加HIV相关性肺动脉高压的发生率。我们的初步数据表明,一些HAART药物在体外可损害猪肺动脉内皮依赖性的血管松弛,减少内皮型一氧化氮合酶(ENOS)的表达,增加超氧阴离子的产生。此外,一些HAART药物还可增加内皮通透性和氧化应激,并降低人肺动脉内皮细胞(HPAECs)几种连接分子的表达。此外,人参皂苷RBL和银杏内酯A能有效阻断HAART药物诱导的内皮功能障碍。在这些研究的基础上,我们提出了我们的中心假设,即某些HAART药物可能通过独特的分子途径导致肺动脉内皮细胞功能障碍和氧化应激,而人参和银杏化合物可能有效地阻断HAART药物对肺动脉的这些不利影响。因此,我们建议进行一项多学科研究来检验这些中心假设。提出了四个具体目标。
目的1研究HAART药物对猪和人肺动脉内皮细胞血管运动活性和eNOS系统的影响。我们将研究血管舒缩活性,eNOS的表达,信号转导途径,以及前列腺素和内皮素系统。
目的2研究HAART药物对内皮细胞通透性、连接结构和分子的影响。我们将研究内皮通透性、连接分子的表达、调节以及信号转导途径。
目的3研究HAART药物对猪和人肺动脉内皮细胞ROS系统的影响。我们将研究ROS产生的类型和分子来源,ROS产生和内部抗氧化酶的活性和基因表达。
目的4研究人参、银杏化合物对HAART药物诱导的猪和人肺动脉内皮细胞内皮功能障碍和氧化应激的影响。我们将研究人参和银杏化合物是否能阻断一些HAART药物引起的血管舒缩功能障碍和通透性增加,以及氧化应激和相关基因的表达和调节。人参和银杏化合物与维生素C和维生素E在阻断HAART诱导的内皮功能障碍方面的差异将进行比较。
本研究将阐明HAART药物对肺内皮细胞作用的分子机制,为制定有效的防治HIV相关性肺动脉高压的策略提供有价值的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changyi Chen其他文献
Changyi Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changyi Chen', 18)}}的其他基金
Natural Substance Derivative DHNB is A Novel Xanthine Oxidase Inhibitor
天然物质衍生物DHNB是一种新型黄嘌呤氧化酶抑制剂
- 批准号:
8443691 - 财政年份:2013
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer
分子外科医生胰腺癌遗传学和基因组学研讨会
- 批准号:
7408620 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7343457 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8316269 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7902294 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7676707 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8132897 - 财政年份:2008
- 资助金额:
$ 36.62万 - 项目类别:
Molecular Surgeon Symposium on Vascular Injury, Repair
分子外科医生血管损伤、修复研讨会
- 批准号:
7057158 - 财政年份:2005
- 资助金额:
$ 36.62万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7250204 - 财政年份:2005
- 资助金额:
$ 36.62万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7037236 - 财政年份:2005
- 资助金额:
$ 36.62万 - 项目类别:
相似海外基金
Complementary and alternative medicine for drug-induced gingival overgrowth: inhibitory effect of TRPA1 channel by lutein
药物性牙龈增生的补充和替代医学:叶黄素对 TRPA1 通道的抑制作用
- 批准号:
23K09321 - 财政年份:2023
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Complementary alternative medicine contributes to attenuate orofacial pain: anesthetic and anti-inflammatory effects of phytochemical
补充替代医学有助于减轻口面部疼痛:植物化学物质的麻醉和抗炎作用
- 批准号:
22K10232 - 财政年份:2022
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Negotiating distinctions between conventional and alternative medicine in the English- and French-language Wikipedias
英语和法语维基百科中讨论传统医学和替代医学之间的区别
- 批准号:
AH/V013203/1 - 财政年份:2021
- 资助金额:
$ 36.62万 - 项目类别:
Research Grant
Systematic study on legal regulations for complementary and alternative medicine
补充替代医学法律法规的系统研究
- 批准号:
19K21680 - 财政年份:2019
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Contribution of complementary alternative medicine to the orthodontic tooth-movement induced inflammatory pain: a possible role of dietary constituent
补充替代医学对正畸牙齿移动引起的炎症性疼痛的贡献:饮食成分的可能作用
- 批准号:
19K10415 - 财政年份:2019
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of complementary and alternative medicine for breast cancer based on kinetic characteristics of food components
基于食物成分动力学特征的乳腺癌补充替代医学应用
- 批准号:
18K14416 - 财政年份:2018
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the Mechanism of Care Effectiveness Using Complementary and Alternative Medicine Material Detergent for Radiation Skin Damage
阐明补充和替代药物材料清洁剂对放射性皮肤损伤的护理效果机制
- 批准号:
18K17460 - 财政年份:2018
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Quality of clinical research papers on complementary and alternative medicine: evaluation with modified systematic reviews
补充和替代医学临床研究论文的质量:用修改后的系统评价进行评估
- 批准号:
17K08938 - 财政年份:2017
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Formulation for the Application of the Energy Therapy "Reiki" as Complementary and Alternative Medicine for Cancer Patient
应用能量疗法“灵气”作为癌症患者的补充和替代医学的配方
- 批准号:
16K15906 - 财政年份:2016
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Boundaries between Orthodox Medicine and Alternative Medicine
正统医学与替代医学之间的界限
- 批准号:
16K21422 - 财政年份:2016
- 资助金额:
$ 36.62万 - 项目类别:
Grant-in-Aid for Young Scientists (B)